Crohn's disease Trials in Mexico, United States
Conditions / Crohn's disease / Mexico, United States
Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.
29 total trials for this combination
Showing top 10 of 29 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00783692 | Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease | COMPLETED | PHASE3 |
| NCT00771667 | A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy | COMPLETED | PHASE2 |
| NCT01696396 | Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease | COMPLETED | PHASE2 |
| NCT01318993 | Open-Label Extension Study of GSK1605786A | TERMINATED | PHASE3 |
| NCT02065570 | Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease | COMPLETED | PHASE3 |
| NCT01316939 | GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease | TERMINATED | PHASE3 |
| NCT01536418 | An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease | TERMINATED | PHASE3 |
| NCT01276509 | Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease | COMPLETED | PHASE2 |
| NCT00195715 | Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease | COMPLETED | PHASE3 |
| NCT00844285 | SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry | COMPLETED | — |